Form 4: Tenet Healthcare Director Tammy Romo Reports Insider Stock Transactions and New RSU Grant

Tenet Healthcare Corp. Director Tammy Romo reported the acquisition of common stock through RSU settlement, a subsequent sale of shares, and the grant of new restricted stock units.

Summary

• Tammy Romo, a Director at Tenet Healthcare Corp (THC), reported changes in her beneficial ownership of company securities.
• On May 23, 2025, Romo acquired 1,551 shares of common stock through the settlement of restricted stock units.
• Concurrently, she disposed of 465 shares of common stock at a price of $161.33 per share.
• Following these transactions, her direct beneficial ownership of common stock stands at 62,366 shares.
• On May 22, 2025, Romo was granted 1,333 new restricted stock units (RSUs) under the Company's Stock Incentive Plan.
• These newly granted RSUs are equivalent to one share of common stock each and are scheduled to vest on May 22, 2026.
• For the newly granted RSUs, the reporting person has the option to receive up to 37% in cash instead of shares upon vesting.
• The previously settled 1,551 RSUs were settled with 30% in cash and 70% in shares.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive due to the grant of new restricted stock units, which aligns the director's interests with the company's long-term performance. However, the partial cash settlement of previous RSUs and the sale of common stock introduce a slight negative aspect, making it a mixed but generally routine insider transaction.

Positives

• Grant of 1,333 new Restricted Stock Units (RSUs) to Director Tammy Romo, aligning her interests with shareholder value.
• The acquisition of 1,551 common stock shares from the settlement of previous RSUs increases direct equity ownership.

Negatives

• Disposition of 465 shares of common stock at $161.33 per share, reducing direct equity exposure.
• Settlement of 30% of 1,551 restricted stock units for cash rather than shares, indicating a partial reduction in equity holding.

Future Outlook

This document is a report of past insider transactions and a future vesting event for RSUs. It does not contain forward-looking statements or guidance on the company's performance or strategy.

Industry Context

This Form 4 filing reports routine insider stock transactions for a director of Tenet Healthcare Corp, a major healthcare services provider. Such transactions are common across all industries as part of executive compensation and personal financial management, and do not inherently reflect broader industry trends unless they are part of a widespread pattern of insider buying/selling across the sector.

Comparison to Industry Standards

• This document reports specific insider transactions and does not provide data for comparison to industry-wide financial or operational benchmarks. Insider transaction patterns can be compared across companies, but this single filing does not offer enough context for a meaningful comparison of company performance against peers like HCA Healthcare or Universal Health Services.

Stakeholder Impact

• Shareholders: The grant of new RSUs aligns director interests with shareholders. The sale of shares by an insider could be perceived negatively, but the overall transaction is routine.

Next Steps

• Vesting of 1,333 Restricted Stock Units on May 22, 2026.

Key Dates

Keywords

Tenet Healthcare, THC, Form 4, Insider Trading, Stock Transactions, Restricted Stock Units, RSU, Director, Equity Ownership, SEC Filing